Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target

Wei, HJ; Xu, YH; Wang, YB; Xu, LT; Mo, CY; Li, LZ; Shen, B; Sun, Y; Cheng, PZ; Yang, L; Pang, YC; Qin, A; Cao, Y; Morrison, SJ; Yue, R

Yue, R (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Inst Regenerat Med,Shanghai East Hosp,Frontier Sc, Shanghai 200092, Peoples R China.

CELL REPORTS, 2020; 33 (2):


Osteogenic suppressors such as Sclerostin not only regulate skeletal development and regeneration but also serve as anti-osteoporosis drug targets. Ho......

Download PDF

Full Text Link